TETRAPHASE PHARMACEUTICALS INC Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
TETRAPHASE PHARMACEUTICALS INC had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $2.30 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2020-05-07
- 2020-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $2.30M.
- 2019-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $3.10M.
- 2019-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $4.40M.
- 2019-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $7.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2020-03-31 | $2.30M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.10M 10-K · filed 2020-03-12 |
| 2019-09-30 | $4.40M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $7.60M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $11.40M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $13.40M 10-K · filed 2019-03-15 |
| 2018-09-30 | $15.80M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $18.40M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $20.90M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $16.10M 10-K · filed 2018-03-06 |
| 2017-09-30 | $19.20M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $21.80M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $23.60M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $18.40M 10-K · filed 2017-03-13 |
| 2016-09-30 | $20.40M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $23.10M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $30.40M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $24.80M 10-K · filed 2016-02-25 |
| 2015-09-30 | $33.60M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $30.70M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $34.40M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $11.70M 10-K · filed 2015-03-06 |
| 2013-12-31 | $5.60M 10-K · filed 2014-03-06 |